Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2012
Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting programYves Longtin, Sylvie Trottier, Gilles Brochu, et al.The Lancet. Microbe|May 11, 2022
Role of high-risk antibiotic use in incidence of health-care-associated Clostridioides difficile infection in Quebec, Canada: a population-level ecological studyElise Fortin, Daniel J G Thirion, Manale Ouakki, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Impact of Isolating Clostridium difficile Carriers on the Burden of Isolation Precautions: A Time Series AnalysisYasi Xiao, Bianka Paquet-Bolduc, Christophe Garenc, et al.Molecular Medicine (Cambridge, Mass.)|June 25, 2002
The alpha 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family StudyChristophe Garenc, Louis Pérusse, Yvon C Chagnon, et al.Obesity Research|May 13, 2003
Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family StudyChristophe Garenc, Louis Pérusse, Yvon C Chagnon, et al.JAMA Internal Medicine|April 26, 2016
Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled StudyYves Longtin, Bianka Paquet-Bolduc, Rodica Gilca, et al.JAMA Network Open|October 14, 2022
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaSara Carazo, Danuta M Skowronski, Marc Brisson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.Pageof 2